Search

A recent meta-analysis conducted at the University Clinical Centre of Kosovo focused on the management of children with heterozygous familial hypercholesterolemia (HeFH) worldwide. The study evaluated the efficacy and safety of lipid-lowering therapy (LLT) in achieving LDL-C goals in pediatric patients with HeFH. Results showed that combination therapy with statins and ezetimibe, as well as PCSK9 inhibitors, were more effective in reducing LDL-C levels compared to other treatments. Despite the efficacy of LLT, achieving LDL-C treatment goals was relatively rare, with significant differences observed between countries. The study highlights the importance of early combination therapy to effectively attain LDL-C goals in children with HeFH. [Extracted from the article]

A recent study conducted at West Virginia University highlights the significance of elevated Lipoprotein(a) levels as a crucial risk factor for cardiovascular diseases and aortic stenosis, affecting a significant portion of the global population. The research emphasizes the importance of exploring novel therapies such as pelacarsen, zerlasiran, and others, which show promise in lowering Lp(a) levels and potentially transforming the management of cardiovascular disease. While these emerging therapies offer hope for at-risk patients, further research is needed to assess their long-term efficacy and safety, heralding a new era in cardiovascular disease prevention and treatment. [Extracted from the article]

A study conducted by researchers at Shahid Beheshti University of Medical Sciences focused on the trajectories of lipid profiles during adolescence and their impact on subclinical atherosclerosis in early adulthood. The study, which included 1006 participants, found that unfavorable changes in lipid parameters were significantly associated with higher carotid intima-media thickness (cIMT) values, highlighting the importance of monitoring lipid levels from early adolescence. The findings suggest that early-life lipid profile trajectories may play a crucial role in the development of cardiovascular diseases in young adults. [Extracted from the article]

A recent study from the University of Turin sheds light on Tangier disease, a rare inherited disorder affecting lipoprotein metabolism and high-density lipoprotein recycling. The research highlights a unique case of an elderly patient with homozygous Tangier disease who presented with mild neurological symptoms and asymptomatic atherosclerosis due to a specific protein mutation. This study underscores the importance of early diagnosis and monitoring for individuals with Tangier disease to prevent cardiovascular events and neuropathy. [Extracted from the article]

A study conducted by Capital Medical University in Beijing, China, explored the impact of statins on ischemic stroke outcomes beyond low-density lipoprotein cholesterol (LDL-C) levels. The research, which included over 800,000 patients, found that statins reduced in-hospital mortality and stroke severity, with the effects persisting even after matching for LDL-C levels. The study suggests that statins may have neuroprotective effects in addition to their lipid-lowering properties, emphasizing the importance of considering these factors in stroke treatment. [Extracted from the article]

Researchers at Huazhong University of Science and Technology conducted a study on the interaction of polychlorinated biphenyls (PCBs), lifestyle, and genetic risk in dyslipidemias. The study found that PCB exposure is associated with an increased prevalence of dyslipidemias, especially when combined with genetic susceptibility and unhealthy lifestyles. The research highlights the importance of reducing PCB exposure and adopting healthy lifestyles to prevent dyslipidemia. This study may contribute to efforts to regulate PCB pollution and control blood lipids to address the dyslipidemia epidemic. [Extracted from the article]

A clinical trial comparing ultrasound lipolysis and cryolipolysis on lipid profile levels in centrally obese middle-aged men is being conducted. The study aims to assess the impact of these treatments on cholesterol, triglyceride levels, body mass index, skin thickness, waist circumference, and waist-hip ratio. The trial involves interventions with ultrasound lipolysis, cryolipolysis, and a low-calorie diet, targeting improvements in body profile and lipid profile. The study is being conducted in Egypt and is not yet recruiting participants, with a completion date set for April 5, 2025. [Extracted from the article]

A study conducted by the National Academy of Sciences of Ukraine focused on the impact of N-stearoylethanolamine (NSE) intake on plasma lipoproteins, adiponectin, and adipocyte cholesterol-phospholipid composition in rats with diet-induced obesity and insulin resistance. The research found that chronic dietary fat overloading led to obesity, dyslipidemia, and changes in plasma adiponectin levels in rats of different ages. NSE administration positively affected the normalization of adiponectin levels and showed potential as a treatment for metabolic disorders associated with obesity and age. The study was published in The Ukrainian Biochemical Journal and can be accessed for free online. [Extracted from the article]

Researchers at Islamic Azad University conducted a study on the effects of 12 weeks of basic gymnastics exercises on body composition and lipid profiles in obese children. The study involved 30 obese girls aged 9.4 years, with the results showing a significant reduction in fat percentage and BMI, as well as improvements in cholesterol levels. The research suggests that basic gymnastics training can have beneficial effects on body composition and lipid profiles in obese children, recommending its use to improve these factors. [Extracted from the article]

A recent study from the Medical University of Lodz in Poland explores the protective role of High-Density Lipoprotein (HDL) in Multiple Sclerosis (MS). The research suggests that HDL may have a positive impact on the blood-brain barrier by reducing its permeability and exerting anti-inflammatory effects. This study highlights the potential of HDL as a mediator of the anti-inflammatory response in MS, offering new insights into the disease. [Extracted from the article]

Researchers from Fu Wai Hospital in Beijing, China, conducted a study on 10,724 patients who underwent percutaneous coronary intervention (PCI) to investigate the impact of lipoprotein(a) [Lp(a)], low-density lipoprotein cholesterol (LDL-C), and high-sensitivity C-reactive protein (hs-CRP) levels on all-cause death. The study found that elevated Lp(a) levels were associated with a higher risk of death in patients with LDL-C levels of 70 mg/dL or higher and hs-CRP levels of 2 mg/L or higher. The researchers concluded that controlling LDL-C levels may mitigate the adverse effects of increased Lp(a) on cardiovascular risk, and that the combined levels of LDL-C and hs-CRP play a role in the long-term outcomes of patients undergoing PCI. [Extracted from the article]

A study conducted at University Hospital Schleswig Holstein in Lubeck, Germany, focused on identifying potential biomarkers for systemic sclerosis with interstitial lung disease (SSc-ILD). The research found that patients with SSc-ILD and lung fibrosis had reduced levels of high-density lipoproteins (HDL) and apolipoproteins A1 + A2. These findings suggest that HDL and its lipoproteins could serve as new biomarkers for SSc-ILD, indicating a need for further evaluation in individualized assessments. The study was published in Respiratory Medicine and can be accessed for more information. [Extracted from the article]

A recent study conducted at Shandong Normal University explored the effects of palmitoleic acid (POA) on liver function, intestinal microbiota, and trimethylamine-N-oxide (TMAO) levels in mice treated with high L-carnitine. The research found that POA consumption could alleviate liver injury induced by high L-carnitine intake by reducing TMAO levels and modulating antioxidant enzyme activities. Additionally, POA was shown to regulate the composition of intestinal microbiota, impacting specific bacteria related to liver injury. This study highlights the potential of POA in repairing liver damage caused by high L-carnitine intake. [Extracted from the article]

A recent study conducted at the University of the Witwatersrand in South Africa focused on the role of metabolites and lipoproteins in predicting the severity of early acute pancreatitis (AP) in a South African cohort. The research aimed to understand the pathophysiological conditions of AP among individuals of African descent to improve prognosis and management. Findings indicated that dysregulated metabolites and lipoproteins could differentiate AP disease states and severity, offering insights into the complex pathophysiology of AP. The study highlighted the potential of integrating clinical parameters with metabolic and lipoprotein data to enhance understanding and management of AP. [Extracted from the article]

A recent study conducted at the Affiliated Hospital of Nantong University examined the relationship between non-high-density lipoprotein cholesterol (non-HDL-C) levels and postoperative distant metastasis in stages I to III colorectal cancer (CRC). The research found that high levels of non-HDL-C (4.1 mmol/L) were associated with an increased risk of distant metastasis and a shorter duration of survival without distant metastasis. These findings suggest that non-HDL-C levels may potentially serve as predictors for postoperative distant metastasis in CRC patients. [Extracted from the article]